Bisphosphonate exposure and Atypical Femoral Fractures JBMR 2012;27:2544 (Figs. 4, 2) Reproduced from J Bone Miner Res 2012;27:2544-50 with permission of the American Society of Bone and Mineral Research.
Cortical thickness and Atypical Fractures Osteoporos Int 2012;23:2893 (Fig. 1) Reproduced from Osteoporos Int 2012;23:2893-6 with permission from Springer.
N Engl J Med 2012;367:1714 (Fig. 2) From N Engl J Med, Steven Boonen, Jean-Yves Reginster, Jean-Marc Kaufman, et al., Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis, Volume 367, Page 1714. Copyright © (2012) Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.
*p<0.05 vs baseline p<0.001 vs placebo N Engl J Med 2012;367:1714 (Fig. 3) From N Engl J Med, Steven Boonen, Jean-Yves Reginster, Jean-Marc Kaufman, et al., Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis, Volume 367, Page 1714. Copyright © (2012) Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.
Bone 2012;50:1115 (Fig. 2) Reproduced from Bone, 50:1115-22, Copyright (2012), with permission from Elsevier.
Bone 2012;50:1115 (Figs. 4, 5) Reproduced from Bone, 50:1115-22, Copyright (2012), with permission from Elsevier.
1-year fracture incidence by age Types of fractures Osteoporos Int 2012;23:2863 (Figs. 1, 3) Reproduced from Osteoporos Int 2012;23:2863-71 with permission from Springer.